YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
12.25
+2.13 (21.05%)
At close: Nov 14, 2025, 4:00 PM EST
12.49
+0.24 (1.96%)
After-hours: Nov 14, 2025, 7:12 PM EST
YD Bio Market Cap
YD Bio has a market cap or net worth of $861.42 million as of November 14, 2025. Its market cap has increased by 1,612.51% in one year.
Market Cap
861.42M
Enterprise Value
858.31M
1-Year Change
1,612.51%
Ranking
Category
Stock Price
$12.25
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $861.42M, an increase of 480.64%. That is a compound annual growth rate of 43.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 861.42M | 1,798.26% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | 144.79M | -2.40% |
| Dec 23, 2020 | 148.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |